Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in more than 10 countries worldwide.
Industry, Sector and Symbol
Stock Exchange TSE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolTSE:ACB
Previous Symbol
CUSIPN/A
Phone+1-604-3625207
Debt
Debt-to-Equity Ratio6.61
Current Ratio6.54
Quick Ratio5.43
Price-To-Earnings
Trailing P/E Ratio26.41
Forward P/E Ratio53.71
P/E GrowthN/A
Sales & Book Value
Annual SalesC$76.62 million
Price / Sales97.53
Cash FlowC$0.51 per share
Price / Cash Flow14.84
Book ValueC$4.57 per share
Price / Book1.64
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares993,706,000
Market CapC$0.00
OptionableNot Optionable
Aurora Cannabis (TSE:ACB) Frequently Asked Questions
What is Aurora Cannabis' stock symbol?
Aurora Cannabis trades on the Toronto Stock Exchange (TSX) under the ticker symbol "ACB."
How were Aurora Cannabis' earnings last quarter?
Aurora Cannabis Inc (TSE:ACB) announced its quarterly earnings data on Monday, November, 12th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.04) by $0.16. The company had revenue of $29.67 million for the quarter, compared to the consensus estimate of $39.50 million. View Aurora Cannabis' Earnings History.
When is Aurora Cannabis' next earnings date?
What price target have analysts set for ACB?
2 equities research analysts have issued 1-year target prices for Aurora Cannabis' stock. Their predictions range from C$9.00 to C$13.00. On average, they expect Aurora Cannabis' share price to reach C$11.00 in the next twelve months. This suggests a possible upside of 48.2% from the stock's current price. View Analyst Price Targets for Aurora Cannabis.
What is the consensus analysts' recommendation for Aurora Cannabis?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aurora Cannabis.
Has Aurora Cannabis been receiving favorable news coverage?
Media coverage about ACB stock has trended somewhat positive on Tuesday, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aurora Cannabis earned a coverage optimism score of 2.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an impact on the stock's share price in the next few days.
Who are some of Aurora Cannabis' key competitors?
Some companies that are related to Aurora Cannabis include Acerus Pharmaceuticals (ASP), Aequus Pharmaceuticals (AQS), Amryt Pharma (AMYT), Aphria (APH), Bausch Health Companies (BHC), Benchmark (BMK), Biosyent (RX), Cannabis Science (CBIS), Canopy Growth (WEED), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), Cipher Pharmaceuticals (CPH), Cosmos (COSM) and CV Sciences (CVSI).
Who are Aurora Cannabis' key executives?
Aurora Cannabis' management team includes the folowing people:
- Mr. Terry Booth, Founder, CEO & Director (Age 53)
- Mr. Stephen Dobler, Founder, Pres & Director (Age 53)
- Mr. Glen Ibbott, Chief Financial Officer
- Mr. Allan John Cleiren, Chief Operating Officer
- Mr. Neil Belot, Chief Global Bus. Devel. Officer
Who are Aurora Cannabis' major shareholders?
Aurora Cannabis' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Gulf International Bank UK Ltd (0.00%).
Which institutional investors are buying Aurora Cannabis stock?
ACB stock was purchased by a variety of institutional investors in the last quarter, including Gulf International Bank UK Ltd.
How do I buy shares of Aurora Cannabis?
Shares of ACB and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Aurora Cannabis' stock price today?
One share of ACB stock can currently be purchased for approximately C$7.42.
What is Aurora Cannabis' official website?
How can I contact Aurora Cannabis?
Aurora Cannabis' mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company can be reached via phone at +1-604-3625207.
MarketBeat Community Rating for Aurora Cannabis (TSE ACB)
MarketBeat's community ratings are surveys of what our community members think about Aurora Cannabis and other stocks. Vote "Outperform" if you believe ACB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACB will underperform the S&P 500 over the long term. You may vote once every thirty days.
